Enliven Therapeutics, Inc. ($ELVN)
Hohl Benjamin โ CHIEF FINANCIAL OFFICER
Shares
150,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Hohl Benjamin |
|---|---|
| Title | CHIEF FINANCIAL OFFICER |
| Transaction Date | Feb 12, 2026 |
| Expiration Date | Feb 12, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Shares Purchased | 150,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 150,000 |
| Derivative | Derivative |
| Accession Number | 0001882764-26-000001 |
| Document | View SEC Filing |